Last update Sept. 4, 2014
High Risk
We do not have alternatives for Phenylpropanolamine.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Phenylpropanolamine belongs to these groups or families:
Main tradenames from several countries containing Phenylpropanolamine in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 100 | % |
Molecular weight | 188 | daltons |
Protein Binding | Low / Bajo | % |
VD | 4.5 | l/Kg |
Tmax | 0.5 - 2 | hours |
T½ | 3.8 - 4.3 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Appears as part of many compounds for cough relief, mucolytics, expectorants and nose decongestants. Single drug (one active principle only) medicines should be preferred mostly while breastfeeding.
On latest update relevant data on breastfeeding was not found.
Pharmacokinetic data indicates that drug excretion into breast milk may occur.
Withheld from marketing in many countries because of hypertension and severe side effects.